Xiaoping Ren | Health Professions | Best Innovation Award

Posted on by ScienceFather

Prof. Dr. Xiaoping Ren | Health Professions | Best Innovation Award

Professor at Lisnom Health, CA, United States

Professor Xiaoping Ren is a globally renowned medical innovator and a leading figure in spinal cord injury treatment and regenerative medicine. As the Chief Scientist of the Global Initiative for the Cure of Paraplegia and Chief Scientific Officer of Lisnom Health, USA, he has pioneered groundbreaking procedures such as the world’s first cephalosomatic anastomosis (head-body transplant) in a mouse model and developed the revolutionary Spinal Cord Fusion (SCF/GEMINI Protocol) using PEG cocktails. With over 70 high-impact SCI publications, multiple international patents, and prestigious awards including the X-PRIZE for life extension, Professor Ren’s contributions have significantly advanced neurosurgery and reconstructive microsurgery. He holds leadership roles at Guangxi University of Chinese Medicine and has served in academic and clinical positions across top institutions in China and the USA. His visionary research and clinical innovations make him a highly deserving candidate for the Best Innovation Award, representing true excellence in medical science and translational impact.

Professional Profile 

Education🎓

Professor Xiaoping Ren has a distinguished educational background that laid the foundation for his groundbreaking medical innovations. He began his medical education in China, where he developed a strong interest in orthopedic surgery and microsurgery. His pursuit of advanced knowledge led him to internationally recognized institutions, including training and fellowships in hand microsurgery at the Kleinert Hand Center, University of Louisville School of Medicine, USA. Throughout his academic journey, Professor Ren has continuously expanded his expertise by engaging in rigorous clinical research and translational medicine. He has held academic roles at the University of Cincinnati and the University of Chicago, where he contributed to the development of cutting-edge surgical techniques. His academic appointments and training in both China and the United States have provided him with a unique cross-cultural and multidisciplinary perspective. This robust educational background has been instrumental in shaping his leadership in spinal cord regeneration and complex reconstructive surgery worldwide.

Professional Experience📝

Professor Xiaoping Ren has over three decades of exceptional professional experience in orthopedic surgery, reconstructive microsurgery, and translational medical research. He began his clinical career in 1984 at Harbin First Hospital, advancing through roles from Resident to Deputy Director of Orthopedics. His international journey includes pivotal academic and clinical positions in the United States, such as Hand Fellow at the University of Louisville, and Assistant/Associate Professor at the University of Cincinnati. He also served as Adjunct Professor and Laboratory Director at the University of Chicago’s Medical Transformation Center. From 2012 to 2018, he held senior roles at Harbin Medical University, leading departments in orthopedics and hand microsurgery. Currently, he is a Professor and Director at Guangxi University of Chinese Medicine and its affiliated Ruikang Hospital. Professor Ren’s extensive global experience has fueled his leadership in groundbreaking innovations, including spinal cord fusion and head-body transplantation models, making him a transformative figure in modern medicine.

Research Interest🔎

Professor Xiaoping Ren’s research interests lie at the forefront of regenerative medicine, neurosurgery, and advanced microsurgical techniques. His primary focus is on spinal cord injury repair and functional restoration through innovative approaches such as the Spinal Cord Fusion (SCF/GEMINI Protocol) using PEG-based cocktails. He is also deeply involved in cephalosomatic anastomosis (head-body transplantation), pushing the boundaries of reconstructive surgery and neural integration. In addition, his work in hand transplantation and peripheral nerve regeneration reflects a broader interest in complex tissue repair and neurovascular reconstruction. Professor Ren is passionate about translational medicine, aiming to bridge experimental breakthroughs with real-world clinical applications. His interdisciplinary approach integrates neuroscience, bioengineering, and clinical surgery to develop life-changing treatments for paralysis and severe trauma. Through global collaborations and cutting-edge experimentation, his research seeks to redefine what is surgically and therapeutically possible in the treatment of catastrophic neurological and musculoskeletal injuries.

Award and Honor🏆

Professor Xiaoping Ren has received numerous prestigious awards and honors in recognition of his groundbreaking contributions to medical science and innovation. He has been honored with the Science and Technology Progress Awards from both the national level in China and the Guangxi regional government for his pioneering work in spinal cord regeneration and reconstructive surgery. Internationally, he was awarded the coveted X-PRIZE for life extension innovations, highlighting his visionary contributions to future-oriented medical solutions. Professor Ren has also been named an influential scientist by the MIT Technology Review, further cementing his global reputation in scientific advancement. He is an Academician of the Russian Academy of Natural Sciences and a Fellow of the International College of Surgeons (USA), accolades that reflect his global impact and leadership in the medical field. His work has been widely featured in international media, including The Wall Street Journal, Discovery Channel, and The New York Times, underscoring his prominence and influence.

Research Skill🔬

Professor Xiaoping Ren possesses an extraordinary range of research skills that have enabled him to lead groundbreaking advancements in regenerative medicine and complex surgical procedures. His expertise spans experimental design, microsurgical techniques, neuroregeneration modeling, and translational research. He is highly skilled in developing innovative protocols, such as the Spinal Cord Fusion (SCF/GEMINI Protocol) using polyethylene glycol (PEG) cocktails, demonstrating his ability to translate molecular-level research into clinical applications. Professor Ren is proficient in conducting animal studies, including cephalosomatic anastomosis models, and has a deep understanding of neural tissue engineering and physiological integration. His capacity to integrate cutting-edge biomedical technologies with surgical practices has led to numerous international patents and high-impact publications. Moreover, his experience in leading multidisciplinary teams and global research collaborations showcases his project management and scientific communication skills. These competencies, combined with his visionary thinking, make him a driving force in medical innovation and a respected leader in international research communities.

Conclusion💡

Professor Xiaoping Ren represents the epitome of medical innovation—fusing bold experimentation, translational science, and global leadership. His SCF/GEMINI Protocol and other pioneering works have the potential to redefine the boundaries of neuroscience, microsurgery, and regenerative medicine.

Publications Top Noted✍️

  • Ren XP, Wu J, Wang X, Sartor MA, Qian J, Jones K, Nicolaou P, et al.
    2009 – 655 citations
    Title: MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20
    Journal: Circulation 119 (17), 2357–2366

  • Wang X, Zhang X, Ren XP, Chen J, Liu H, Yang J, Medvedovic M, Hu Z, et al.
    2010 – 393 citations
    Title: MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury
    Journal: Circulation 122 (13), 1308–1318

  • Diwan A, Krenz M, Syed FM, Wansapura J, Ren X, Koesters AG, Li H, et al.
    2007 – 368 citations
    Title: Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice
    Journal: The Journal of Clinical Investigation 117 (10), 2825–2833

  • Fan GC, Ren X, Qian J, Yuan Q, Nicolaou P, Wang Y, Jones WK, Chu G, et al.
    2005 – 273 citations
    Title: Novel cardioprotective role of a small heat-shock protein, Hsp20, against ischemia/reperfusion injury
    Journal: Circulation 111 (14), 1792–1799

  • Jones WK, Brown M, Ren X, He S, McGuinness M
    2003 – 232 citations
    Title: NF-κB as an integrator of diverse signaling pathways: the heart of myocardial signaling?
    Journal: Cardiovascular Toxicology 3, 229–253

  • Francois CG, Breidenbach WC, Maldonado C, Kakoulidis TP, Hodges A, et al.
    2000 – 216 citations
    Title: Hand transplantation: comparisons and observations of the first four clinical cases
    Journal: Microsurgery

  • Luther KM, Haar L, McGuinness M, Wang Y, Lynch IV TL, Phan A, Song Y, et al.
    2018 – 201 citations
    Title: Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells
    Journal: Journal of Molecular and Cellular Cardiology 119, 125–137

  • Fan GC, Zhou X, Wang X, Song G, Qian J, Nicolaou P, Chen G, Ren X, et al.
    2008 – 201 citations
    Title: Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity
    Journal: Circulation Research 103 (11), 1270–1279

  • Jones WK, Fan GC, Liao S, Zhang JM, Wang Y, Weintraub NL, et al.
    2009 – 198 citations
    Title: Peripheral nociception associated with surgical incision elicits remote nonischemic cardioprotection via neurogenic activation of protein kinase C signaling
    Journal: Circulation 120 (11_suppl_1), S1–S9

  • Wang X, Zhu H, Zhang X, Liu Y, Chen J, Medvedovic M, Li H, Weiss MJ, et al.
    2012 – 166 citations
    Title: Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1
    Journal: Cardiovascular Research 94 (2), 379–390

  • Jones Jr JW, Üstüner ET, Zdichavsky M, Edelstein J, Ren X, Maldonado C, et al.
    1999 – 151 citations
    Title: Long-term survival of an extremity composite tissue allograft with FK506–mycophenolate mofetil therapy
    Journal: Surgery 126 (2), 384–388

  • Qian J, Ren X, Wang X, Zhang P, Jones WK, Molkentin JD, Fan GC, et al.
    2009 – 147 citations
    Title: Blockade of Hsp20 phosphorylation exacerbates cardiac ischemia/reperfusion injury by suppressed autophagy and increased cell death
    Journal: Circulation Research 105 (12), 1223–1231

Liying Zhang | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Liying Zhang | Medicine and Dentistry | Best Researcher Award

Professor at University of California, Los Angeles, United States

Dr. Liying Zhang, MD, PhD, FACMG, is a distinguished researcher and professor specializing in molecular diagnostics and precision oncology. She serves as the Director of the Advanced Molecular Diagnostics Service at UCLA David Geffen School of Medicine and the Director of Cancer Molecular Diagnostics at UCLA Jonsson Comprehensive Cancer Center. With extensive experience in molecular genetics, her research focuses on cancer diagnostics, biomarker discovery, and precision medicine. She has contributed to numerous high-impact studies, secured significant research funding, and played an active role in national and international expert committees. Her expertise spans clinical molecular genetics, genomics, bioinformatics, and laboratory medicine, making her a leading figure in the field of cancer molecular diagnostics.

Professional Profile 

Education

Dr. Zhang earned her Ph.D. in Biochemistry and Molecular Biology from The Johns Hopkins University in 2003, alongside a Master’s degree in Computer Science with a focus on Bioinformatics in 2002. She obtained her MD from Peking University, Beijing, China, in 1994. She holds multiple clinical licensures and board certifications, including Clinical Molecular Genetics and Genomics from the American Board of Medical Genetics and Genomics. Her strong educational foundation in medicine, biochemistry, molecular biology, and computational science has equipped her with the interdisciplinary expertise required for advancing molecular diagnostics and precision medicine.

Professional Experience

Dr. Zhang has held several prestigious roles in molecular pathology and diagnostics. Since 2020, she has been a Professor and Director at UCLA, leading advanced molecular diagnostics initiatives. Previously, she served as a Director and Molecular Geneticist at Memorial Sloan Kettering Cancer Center from 2005 to 2019, overseeing diagnostic molecular genetics laboratories and contributing to groundbreaking cancer research. Her earlier roles include research positions at the National Research Institute for Family Planning in China. Additionally, she has been actively involved in professional committees, journal reviews, and mentorship programs, furthering advancements in molecular diagnostics and genetic research.

Research Interest

Dr. Liying Zhang’s research focuses on molecular diagnostics, cancer genomics, and precision oncology. She is dedicated to identifying genetic biomarkers that enhance cancer detection, prognosis, and treatment strategies. Her work involves integrating next-generation sequencing (NGS) technologies, bioinformatics, and molecular pathology to improve the accuracy and efficiency of cancer diagnostics. She is particularly interested in the molecular mechanisms underlying tumor development, drug resistance, and targeted therapies. Through collaborations with oncologists, geneticists, and data scientists, she aims to translate genetic findings into clinically actionable insights that improve patient outcomes. Her research also extends to liquid biopsy, epigenetics, and the development of novel molecular assays for early cancer detection.

Awards and Honors

Dr. Zhang has received numerous prestigious awards recognizing her contributions to molecular genetics and cancer diagnostics. She has been honored as a Fellow of the American College of Medical Genetics and Genomics (FACMG), acknowledging her leadership and expertise in clinical molecular genetics. She has also received research excellence awards from institutions such as Memorial Sloan Kettering Cancer Center and UCLA for her groundbreaking work in cancer molecular diagnostics. Additionally, she has been an invited speaker at leading international conferences, including the American Society of Human Genetics (ASHG) and the Association for Molecular Pathology (AMP). Her contributions to scientific research and clinical practice have earned her recognition as a thought leader in precision medicine and molecular oncology.

Research Skills

Dr. Zhang possesses a diverse range of research skills in molecular diagnostics and genomics. She is proficient in next-generation sequencing (NGS) technologies, whole-genome and transcriptome analysis, and single-cell sequencing. She has extensive experience in bioinformatics, data mining, and computational modeling for genetic variant interpretation. Her expertise includes designing and validating molecular assays for clinical diagnostics, including PCR-based and hybrid capture-based sequencing methods. She is also skilled in laboratory management, regulatory compliance, and quality control in clinical molecular genetics laboratories. Additionally, her strong background in translational research allows her to bridge the gap between basic scientific discoveries and clinical applications, ensuring that her findings have a direct impact on patient care and personalized treatment strategies.

Conclusion

Dr. Liying Zhang is highly suitable for the Best Researcher Award due to her exceptional contributions to molecular diagnostics, cancer genomics, and precision medicine. Her extensive experience in research leadership, grant acquisition, and clinical applications makes her an outstanding candidate. Strengthening her independent research leadership and international collaborations would further solidify her candidacy for this prestigious award.

Publications Top Noted

  • Title: Inherited DNA-repair gene mutations in men with metastatic prostate cancer
    Authors: CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, …
    Year: 2016
    Citation: 1765

  • Title: Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
    Authors: L Klotz, L Zhang, A Lam, R Nam, A Mamedov, A Loblaw
    Year: 2010
    Citation: 1402

  • Title: Long-term follow-up of a large active surveillance cohort of patients with prostate cancer
    Authors: L Klotz, D Vesprini, P Sethukavalan, V Jethava, L Zhang, S Jain, …
    Year: 2015
    Citation: 1399

  • Title: CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct
    Authors: IYL Tan, AM Demchuk, J Hopyan, L Zhang, D Gladstone, K Wong, …
    Year: 2009
    Citation: 792

  • Title: Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
    Authors: J Holzbeierlein, P Lal, E LaTulippe, A Smith, J Satagopan, L Zhang, …
    Year: 2004
    Citation: 708

  • Title: Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Authors: A Latham, P Srinivasan, Y Kemel, J Shia, C Bandlamudi, D Mandelker, …
    Year: 2019
    Citation: 591

  • Title: Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Authors: W Abida, J Armenia, A Gopalan, R Brennan, M Walsh, D Barron, D Danila, …
    Year: 2017
    Citation: 583

  • Title: Celiac disease: summary
    Authors: A Rostom, C Dubé, A Cranney, N Saloojee, R Sy, C Garritty, M Sampson, …
    Year: 2004
    Citation: 511

  • Title: Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Authors: D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph, A Zehir, …
    Year: 2017
    Citation: 508

  • Title: Tumour lineage shapes BRCA-mediated phenotypes
    Authors: P Jonsson, C Bandlamudi, ML Cheng, P Srinivasan, SS Chavan, …
    Year: 2019
    Citation: 384

  • Title: Hereditary diffuse gastric cancer: updated clinical practice guidelines
    Authors: VR Blair, M McLeod, F Carneiro, DG Coit, JL D’Addario, JM van Dieren, …
    Year: 2020
    Citation: 381

  • Title: Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases
    Authors: E Chow, P Hoskin, G Mitera, L Zeng, S Lutz, D Roos, C Hahn, …
    Year: 2012
    Citation: 374

  • Title: Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data
    Authors: S Middha, L Zhang, K Nafa, G Jayakumaran, D Wong, HR Kim, …
    Year: 2017
    Citation: 363

  • Title: Genetic predictors of response to systemic therapy in esophagogastric cancer
    Authors: YY Janjigian, F Sanchez-Vega, P Jonsson, WK Chatila, JF Hechtman, …
    Year: 2018
    Citation: 352

Mohammad-Hossein Keivanlou | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr.Mohammad-Hossein Keivanlou | Medicine and Dentistry | Best Researcher Award

Doctor of Medicine at Guilan University Of Medical Sciences, Iran

Mohammad-Hossein Keivanlou is a dedicated medical researcher currently pursuing his Doctor of Medicine (M.D.) at Guilan University of Medical Sciences, Iran. With a strong background in medical research and epidemiology, he has gained proficiency in data analysis, scientific writing, and systematic reviews using tools like R, Stata, SPSS, and VOSviewer. Keivanlou has contributed significantly to medical research, earning the “Best Medical Researcher Award” for 2023 and 2024. He has also been recognized for his academic achievements, ranking 7th in the nationwide Pre-Internship Examination in Iran. As a Clinical Research Coordinator at the Gastrointestinal and Liver Diseases Research Center, he has gained valuable hands-on experience, while also mentoring and educating junior medical students in research methodologies. His passion for education, mentorship, and global health research highlights his commitment to both personal growth and advancing medical knowledge.

Professional Profile

Education

Mohammad-Hossein Keivanlou is currently pursuing his Doctor of Medicine (M.D.) at Guilan University of Medical Sciences in Rasht, Iran, a program he has been enrolled in since October 2017. Prior to this, he completed his high school education at the Elite Foundation of Iran, under the National Organization for the Development of Exceptional Talents (Sampad), graduating in October 2017. His academic journey reflects a strong commitment to medical education and research, laying a solid foundation for his future career as a medical researcher and clinician.

Professional Experience

Mohammad-Hossein Keivanlou has gained significant professional experience in the field of medical research. From October 2018 to October 2020, he served as a Medical Research Assistant at Guilan University of Medical Sciences, where he supported research projects and gained hands-on experience in scientific studies. Since October 2020, he has been working as a Clinical Research Coordinator at the Gastrointestinal and Liver Diseases Research Center in Rasht, Iran, where he manages and coordinates clinical research projects, ensuring their smooth execution and adherence to scientific standards. These roles have equipped him with valuable skills in research management, data analysis, and collaboration within the medical research community.

Research Interest

Mohammad-Hossein Keivanlou has a strong research interest in medical research and epidemiology, with a particular focus on exploring disease patterns and contributing to global health through evidence-based studies. His work aims to deepen understanding of various health conditions, particularly within the realms of gastrointestinal and liver diseases, while also advancing knowledge on effective public health strategies. In addition to his core research, he is passionate about mentorship and education, helping to guide and inspire the next generation of medical researchers through training and collaborative learning environments. His broad academic interests reflect a commitment to improving health outcomes and promoting scientific advancements in medicine.

Award and Honor

Mohammad-Hossein Keivanlou has received several prestigious awards and honors in recognition of his outstanding contributions to medical research and academic excellence. Notably, he was awarded the “Best Medical Researcher Award” at Guilan University of Medical Sciences for both 2023 and 2024, honoring his significant achievements in medical research, particularly in epidemiology. In addition to this, he ranked 7th nationwide in the 2024 Pre-Internship Examination in Iran, underscoring his academic prowess. Keivanlou was also recognized for his exceptional presentation skills, earning the “Best Presenter” awards at both the Babol Congress 2023 (Nutrition Panel) and Shahid Beheshti Congress 2023 (Cancer Panel). These accolades reflect his dedication to advancing medical knowledge and his reputation as a leader in his field.

Conclusion

Mohammad-Hossein Keivanlou has already demonstrated exceptional abilities in medical research, clinical coordination, and mentoring. His technical skills and passion for research, combined with his recognitions and awards, make him a strong contender for the Best Researcher Award. By further expanding his publication record and leadership roles, he could solidify his place as a leader in the field.

Publications Top Noted
  • Modulation of inflammatory markers in type 2 diabetes mellitus through gut microbiome-targeted interventions: An umbrella review on meta-analyses
    • Authors: Habibi, A., Letafatkar, N., Sattari, N., Keivanlou, M.-H., Amini-Salehi, E.
    • Year: 2025
    • Citation: Clinical Nutrition ESPEN, 65, pp. 93–104
    • Citations: 0
  • The evolving role of MRI in the detection of extrathyroidal extension of papillary thyroid carcinoma: A systematic review and meta-analysis
    • Authors: Javid, M., Mirdamadi, A., Javid, M., Mansour-Ghanaei, F., Hassanipour, S.
    • Year: 2024
    • Citation: BMC Cancer, 24(1), 1531
    • Citations: 0
  • The association between neutrophil and lymphocyte to high-density lipoprotein cholesterol ratio and metabolic syndrome among Iranian population, finding from Bandare Kong cohort study
    • Authors: Hashemi, S.M., Kheirandish, M., Rafati, S., Saberian, P., Rahimi, A.
    • Year: 2024
    • Citation: Lipids in Health and Disease, 23(1), 393
    • Citations: 0
  • Diagnostic and prognostic value of triglyceride glucose index: A comprehensive evaluation of meta-analysis
    • Authors: Nayak, S.S., Kuriyakose, D., Polisetty, L.D., Hassanipour, S., Amini-Salehi, E.
    • Year: 2024
    • Citation: Cardiovascular Diabetology, 23(1), 310
    • Citations: 9
  • Correction: The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: A comprehensive umbrella review
    • Authors: Vakilpour, A., Amini-Salehi, E., Soltani Moghadam, A., Hassanipour, S., Samethadka Nayak, S.
    • Year: 2024
    • Citation: Nutrition and Diabetes, 14(1), 67
    • Citations: 0
  • The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: A comprehensive umbrella review
    • Authors: Vakilpour, A., Amini-Salehi, E., Soltani Moghadam, A., Hassanipour, S., Samethadka Nayak, S.
    • Year: 2024
    • Citation: Nutrition and Diabetes, 14(1), 25
    • Citations: 4
  • Evaluating biomarkers for contrast-induced nephropathy following coronary interventions: An umbrella review on meta-analyses
    • Authors: Mahapatro, A., Nobakht, S., Mukesh, S., Amini-Salehi, E., Nayak, S.S.
    • Year: 2024
    • Citation: European Journal of Medical Research, 29(1), 210
    • Citations: 3
  • Cardiovascular and all-cause mortality outcomes of adrenalectomy versus medical treatment in primary aldosteronism: An umbrella review
    • Authors: Nayak, S.S., Amini-Salehi, E., Joukar, F., Hassanipour, S., Keivanlou, M.-H.
    • Year: 2024
    • Citation: International Journal of Surgery, 110(11), pp. 7367–7380
    • Citations: 0
  • Global prevalence of nonalcoholic fatty liver disease: An updated meta-analysis on 78 million population over 38 countries
    • Authors: Amini-Salehi, E., Letafatkar, N., Norouzi, N., Patel, D., Nayak, S.S.
    • Year: 2024
    • Citation: Archives of Medical Research, 55(6), 103043
    • Citations: 5
  • Exploring the relationship between gut microbiome modulation and blood pressure in type 2 diabetes: An umbrella review
    • Authors: Amini-Salehi, E., Mahapatro, A., Korsapati, R.R., Keivanlou, M.-H., Patel, D.
    • Year: 2024
    • Citation: Nutrition, Metabolism and Cardiovascular Diseases, 34(9), pp. 2046–2054
    • Citations: 4

Bruno Eto | Clinical phytopharmacology | Academic and Industrial Synergy Award

Posted on by ScienceFather

🌟Assoc Prof Dr. Bruno Eto, Clinical phytopharmacology, Academic and Industrial Synergy Award🏆

Associate professor at Laboratoires TBC, Faculty of Pharmacy, University of Lille, France

Dr. Jane Smith is a highly accomplished researcher and academician in the field of biochemistry. With a Ph.D. in Molecular Biology from XYZ University, she has dedicated her career to advancing our understanding of cellular processes and their implications in health and disease. Dr. Smith’s work combines a strong foundation in biochemistry with cutting-edge technologies to unravel the complexities of molecular interactions.

Author Metrics:

Scopus Profile

Orcid Profile

Google Scholar Profile

Dr. Smith’s research has garnered significant attention, with an h-index of 30 and over 5,000 citations. Her work is not only prolific but also highly influential, shaping the discourse in the field.

  • Citations: 684
  • h-index: 14
  • i10-index: 29

h-index:

The h-index is a measure that reflects both the productivity and impact of a researcher’s work. An h-index of 18 (for the first set) and 14 (for the second set) means that the respective individuals/entities have published at least 18 and 14 papers, each of which has been cited at least that many times.

i10-index:

The i10-index is the number of academic publications by an author/entity that have at least 10 citations from other researchers. A value of 29 suggests that there are 29 publications with at least 10 citations each.

Education:

Dr. Smith earned her Bachelor’s degree in Biochemistry from ABC College, where her passion for understanding the molecular intricacies of life was ignited. Subsequently, she pursued a Master’s degree in Cellular Biology at DEF University, laying the groundwork for her Ph.D. at XYZ University, where she specialized in Molecular Biology.

Research Focus:

Dr. Smith’s research focuses on elucidating the molecular mechanisms underlying cell signaling pathways, with a particular emphasis on cancer biology. Her work spans from basic research, exploring fundamental cellular processes, to translational research, aiming to develop targeted therapies for cancer treatment.

Professional Journey:

Following the completion of her Ph.D., Dr. Smith joined the prestigious Research Institute for Molecular Sciences as a Postdoctoral Fellow. There, she made significant contributions to the understanding of a key signaling pathway implicated in cancer progression. Subsequently, she transitioned to a faculty position at UVW University, where she established her research group, fostering a collaborative and innovative environment.

Honors & Awards:

Throughout her career, Dr. Smith has received numerous accolades, including the Young Scientist Award from the International Society of Molecular Biology and the Outstanding Researcher of the Year accolade from UVW University. These honors reflect her dedication and impact in the field.

Publications Top Noted & Contributions:

Dr. Smith has authored over 50 peer-reviewed publications in high-impact journals, cementing her reputation as a leading expert in biochemistry and molecular biology. Her contributions range from seminal discoveries in cellular signaling to innovative methodologies that have become widely adopted in the scientific community.

Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats

  • Authors: B Meddah, R Ducroc, MEA Faouzi, B Eto, L Mahraoui, …
  • Journal: Journal of Ethnopharmacology
  • Year: 2009
  • Citation Metrics: 285

Chemical constituents and pharmacological actions of carob pods and leaves (Ceratonia siliqua L.) on the gastrointestinal tract: A review

  • Authors: K Rtibi, S Selmi, D Grami, M Amri, B Eto, J El-Benna, H Sebai, L Marzouki
  • Journal: Biomedicine & Pharmacotherapy
  • Year: 2017
  • Citation Metrics: 134

Ceratonia siliqua L. (immature carob bean) inhibits intestinal glucose absorption, improves glucose tolerance and protects against alloxan‐induced diabetes in rat

  • Authors: K Rtibi, S Selmi, D Grami, K Saidani, H Sebai, M Amri, B Eto, L Marzouki
  • Journal: Journal of the Science of Food and Agriculture
  • Year: 2017
  • Citation Metrics: 55

An agile scheduling and control approach in ETO construction supply chains

  • Authors: P Dallasega, RA Rojas, G Bruno, E Rauch
  • Journal: Computers in Industry
  • Year: 2019
  • Citation Metrics: 53

Inventory of medicinal plants used traditionally to manage kidney diseases in north-eastern Morocco: Ethnobotanical fieldwork and pharmacological evidence

  • Authors: N Bencheikh, A Elbouzidi, L Kharchoufa, H Ouassou, I Alami Merrouni, …
  • Journal: Plants
  • Year: 2021
  • Citation Metrics: 52

Research Timeline:

1998-2002: Bachelor’s in Biochemistry, ABC College 2002-2004: Master’s in Cellular Biology, DEF University 2004-2009: Ph.D. in Molecular Biology, XYZ University 2009-2011: Postdoctoral Fellow, Research Institute for Molecular Sciences 2011-Present: Faculty Position, UVW University